Trial intelligence / Profile preview

Remimazolam and Postoperative Sleep in Elderly Patients Undergoing Laparoscopic Colorectal Cancer Resection

NCT07740343Recruiting

Sponsor
General Hospital of Ningxia Medical University
Start
Aug 2026
Primary completion
Jan 2027
Countries
1
01

Overview

Randomised, double-blind trial of remimazolam in Postoperative sleep disturbance (PSD) (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Total sleep time. Started Aug 2026; status: recruiting.

02

Drugs

remimazolam
03

Conditions

Postoperative sleep disturbance (PSD)

Beyond the preview

Go deeper on NCT07740343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07740343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call